BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25991672)

  • 1. Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome.
    Auer K; Bachmayr-Heyda A; Aust S; Sukhbaatar N; Reiner AT; Grimm C; Horvat R; Zeillinger R; Pils D
    Oncotarget; 2015 Jul; 6(19):17261-75. PubMed ID: 25991672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer.
    Auer K; Bachmayr-Heyda A; Aust S; Grunt TW; Pils D
    Cancer Lett; 2017 Mar; 388():158-166. PubMed ID: 27940126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer.
    Auer K; Bachmayr-Heyda A; Sukhbaatar N; Aust S; Schmetterer KG; Meier SM; Gerner C; Grimm C; Horvat R; Pils D
    Oncotarget; 2016 Sep; 7(38):61336-61354. PubMed ID: 27665539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small RNAs and the competing endogenous RNA network in high grade serous ovarian cancer tumor spread.
    Bachmayr-Heyda A; Auer K; Sukhbaatar N; Aust S; Deycmar S; Reiner AT; Polterauer S; Dekan S; Pils D
    Oncotarget; 2016 Jun; 7(26):39640-39653. PubMed ID: 27172797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-Proteasome Axis, Especially Ubiquitin-Specific Protease-17 (
    Yildirim N; Kocal GC; Isik Z; Saatli B; Saygili U; Uysal T; Ulukus C; Koyuncuoglu M; Ellidokuz H; Basbinar Y
    Reprod Sci; 2019 Jun; 26(6):794-805. PubMed ID: 30198418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two different, mutually exclusively distributed,
    Sukhbaatar N; Bachmayr-Heyda A; Auer K; Aust S; Deycmar S; Horvat R; Pils D
    Cold Spring Harb Mol Case Stud; 2017 Jul; 3(4):. PubMed ID: 28679689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Li Y; Fei H; Lin Q; Liang F; You Y; Li M; Wu M; Qu Y; Li P; Yuan Y; Chen T; Jiang H
    Oncogene; 2021 Aug; 40(32):5131-5141. PubMed ID: 34211089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-coding RNA
    Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
    Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
    Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
    Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
    Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer.
    Song IH; Kim KR; Lim S; Kim SH; Sung CO
    Pathol Res Pract; 2018 Oct; 214(10):1564-1571. PubMed ID: 30082157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kindlin-2 inhibits serous epithelial ovarian cancer peritoneal dissemination and predicts patient outcomes.
    Ren C; Du J; Xi C; Yu Y; Hu A; Zhan J; Guo H; Fang W; Liu C; Zhang H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):187-94. PubMed ID: 24583125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modeling of metastatic human high-grade serous ovarian cancer in mice.
    Kim O; Park EY; Klinkebiel DL; Pack SD; Shin YH; Abdullaev Z; Emerson RE; Coffey DM; Kwon SY; Creighton CJ; Kwon S; Chang EC; Chiang T; Yatsenko AN; Chien J; Cheon DJ; Yang-Hartwich Y; Nakshatri H; Nephew KP; Behringer RR; Fernández FM; Cho CH; Vanderhyden B; Drapkin R; Bast RC; Miller KD; Karpf AR; Kim J
    PLoS Genet; 2020 Jun; 16(6):e1008808. PubMed ID: 32497036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer.
    Ye Y; Yin M; Huang B; Wang Y; Li X; Lou G
    Tumour Biol; 2015 Jun; 36(6):4175-9. PubMed ID: 25582317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma.
    Garg R; Wollan M; Galic V; Garcia R; Goff BA; Gray HJ; Swisher E
    Gynecol Oncol; 2006 Dec; 103(3):793-6. PubMed ID: 17023036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect.
    Burdennyy AM; Filippova EA; Ivanova NA; Lukina SS; Pronina IV; Loginov VI; Fridman MV; Kazubskaya TP; Utkin DO; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2021 Jul; 171(3):370-374. PubMed ID: 34292442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
    Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
    J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature.
    Mhawech-Fauceglia P; Izevbaye I; Spindler T; Wang G; Hwang H; Samrao D; Elishaev E; Maxwell GL; Lawrenson K; Darcy KM
    Gynecol Oncol; 2020 Jan; 156(1):6-12. PubMed ID: 31711656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.